Arch Therapeutics, Inc. (ARTH) Stock Analysis
DELISTED
What happened to Arch Therapeutics, Inc. (ARTH) stock?
Arch Therapeutics, Inc. (ARTH) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Arch Therapeutics, Inc. (ARTH). Arch Therapeutics, Inc. is a biotechnology company focused on developing innovative wound management solutions. Utilizing its proprietary AC5 self-assembling technology, the company aims to improve patient outcomes in surgical and trauma care.
Last analyzed: Jun 14, 2026Dated analysis: the newest financial statements on file are 31 months old (Mar 1, 2024), so the figures and score below describe that period, not today.
Arch Therapeutics, Inc. (ARTH) Healthcare & Pipeline Overview
ARTH OTC Market Information
ARTH trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy ARTH shares?
No. ARTH stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ARTH elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ARTH stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Arch Therapeutics, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.